The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
COVID-19 vaccines: breaking record times to first-in-human trials
Open accessAbstract
The twenty-first century has come with a new era in vaccinology, in which recombinant genetic technology has contributed to setting an unprecedented fast pace in vaccine development, clearly demonstrated during the recent COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, MERS-CoV and SARS-CoV vaccines required about 2 years of development before entering phase I trials259 and have yet to be approved.”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [259]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Jänke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,211
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
Duffy, M. R., Chen, T.-H., Hancock, W. T., Powers, A. M., Kool, J. L., Lanciotti, R. S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805715 · Cited by 3,130
Wilder-Smith, A., & Freedman, D. O. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa020 · Cited by 2,727
Zika Virus (I). Isolations and serological specificity
Dick, G. W. A., Kitchen, S. F., & Haddow, A. J. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90042-4 · Cited by 2,698
Research on Dengue during World War II
Sabin, A. B. (1952) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1952.1.30 · Cited by 955
Zika virus (II). Pathogenicity and physical properties
Dick, G. W. A. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90043-6 · Cited by 690
Ross, R. W. (1956) · Journal of Hygiene · doi:10.1017/s0022172400044442 · Cited by 650
Cited by
Sorted by citations
Items 101–117 of 117
Saxena, M., Patil, N., Sareen, M., & Tyagi, N. (2021) · Acta Scientific Dental Scienecs · doi:10.31080/asds.2021.05.1176
Legal responsibility for vaccination against COVID-19 in Ukraine and other countries
Hromovenko, K. V., Minchenko, R., Сарибаєва, Г. М., Batan, Y., & Minchenko, D. (2021) · Revista Amazonia Investiga · doi:10.34069/ai/2021.43.07.26
Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy
Biteghe, F. A. N., Toung, C. N. E., Ndong, J. D. L. C., Mungra, N., Dar, T. B., & Kombe, A. J. K. (2021) · Infectious diseases · doi:10.5772/intechopen.97811
Developing COVID-19’s Vaccines: Short Review
Alsayed, R. (2022) · Journal of Al-Nahrain University-Science · doi:10.22401/anjs.25.1.10
Predicting Corona Virus Affected Patients Using Supervised Machine Learning
David, H. B. F., Suruliandi, A., & Raja, S. P. (2022) · International Journal of Uncertainty Fuzziness and Knowledge-Based Systems · doi:10.1142/s0218488522400086
Notfallimpfstoffe: Wie sieht die Zukunft aus?
Addo, M. M. (2022) · Springer eBooks · doi:10.1007/978-3-662-66073-7_10
Using Natural Language Processing for Context Identification in COVID-19 Literature
Carvalho, F. C., Mariano, D., Bomfim, M., Maia, G. D. C. F., Bastos, L. L., de Abreu, A. P., Paixão, V. M., dos Santos, L. M., Silva, J. M. D., Puelles, A. L. A., et al. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-42715-2_7
Introduction to Public Health and the Fundamentals of Epidemiology
(2024) · Springer Publishing Company eBooks · doi:10.1891/9780826166944.0001
Ye, Y., Zhou, Q., Su, Z., & Gu, Z. H. (2024) · Journal of Community Medicine & Public Health · doi:10.29011/2577-2228.100417
Gerold, M. N., Toth, E., Blair, R. H., Gao, R. Y., Nadkarni, D. V., Barua, S., Woods, J., Rowlen, K. L., & Dawson, E. D. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4849255
Güran, M., Cangert, İ. Y., Sabah, G., Çalışkan, A., Çakan, K., Derin, M. E., & Erdoğan, M. Z. (2024) · Acibadem Universitesi Saglik Bilimleri Dergisi · doi:10.31067/acusaglik.1225105
Sentiment analysis of employees and COVID-19 vaccine hesitancy at workplacePreprint
Akpan, I. J., Warner, T., & Peters, M. (2025) · medRxiv · doi:10.1101/2025.01.30.25321414
Kako nastajajo cepiva mRNK: tehnološki izzivi in rešitve iz laboratorija
Sekirnik, R. (2025) · Alternator · doi:10.3986/alternator.2025.11
Insights from deep mutational scanning in the context of an emerging pathogen
Call, M. J., Call, M. E., & Wu, X. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253033
Vaccinology in the twenty-first century revisited
Barrett, A. D. T., Rupp, R. E., Titball, R. W., & von Messling, V. (2026) · npj Vaccines · doi:10.1038/s41541-026-01552-3 · Cited by 1
Sadawi, A. A., Ndiaye, M., Khaffaf, I. A., & Abdulkarim, O. (2026) · Sensors · doi:10.3390/s26206524
Incidence of adverse events following COVID-19 vaccination in observational studies
do Nascimento, M. C., Lima, K. E. M., Silva, M. E., Lanza, V. B., de Brito, I. M., Galo, V. D. C., Nascimento, A. L. S., Delpino, F. M., & Paranaiba, L. M. R. (2026) · Discover Public Health · doi:10.1186/s12982-026-03094-4
Metadata
- Authors
- Kim, Y. C., Dema, B., & Reyes-Sandoval, A.
- Affiliations
- University of Oxford (GB)
- ORCID
- Kim, Young Chan
- Venue
- npj Vaccines
- Published
- 2020-04-30
- Volume
- 5
- Issue
- 1
- Pages
- 34-34
- ISSN
- 2059-0105 (ISSN-L)
- PMC
- PMC7193619
- OpenAlex
- W3023791804
- Cited by
- 117
- References
- 24
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 26 · 2021: 31 · 2020: 31
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- npj Vaccines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (16/107/05)
- Department of Health and Social Care
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Legal, Health, Environmental and COVID-19 Challenges
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 vaccines, vaccine development timeline, mRNA vaccines, SARS-CoV-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
